We utilized two full‐length AR‐regulated gene signatures: One consisted of genes differentially expressed in tumor versus normal samples and enriched for AR binding sites, obtained from Pomerantz et al (2015), and a second transcription‐based full‐length AR activity signature from Mendiratta et al (2009). This evidence concerns the gene AR and neoplasm.